Data as of Q4 2025 (Dec 31, 2025)
EGRX

EAGLE PHARMACEUTICALS IN

Institutional Ownership ยท Q4 2025

Filing: Q4 2025

EAGLE PHARMACEUTICALS IN (EGRX) is held by 2 institutional investors with combined holdings of $8,645. Major holders include Stanley-Laman Group, Ltd., Archer Investment Corp.

Institutional Holders
2
Total Value
$8.6K
Ownership %
0.1%